Invention Grant
US07670802B2 CXC-chemokine antagonists isolated from Rhipicephalus sanguineus
失效
从龙眼ists ists分离的CXC趋化因子拮抗剂
- Patent Title: CXC-chemokine antagonists isolated from Rhipicephalus sanguineus
- Patent Title (中): 从龙眼ists ists分离的CXC趋化因子拮抗剂
-
Application No.: US12067221Application Date: 2006-10-30
-
Publication No.: US07670802B2Publication Date: 2010-03-02
- Inventor: Amanda Proudfoot , Christine Power
- Applicant: Amanda Proudfoot , Christine Power
- Applicant Address: CH Coinsins, Vaud
- Assignee: Merck Serono SA
- Current Assignee: Merck Serono SA
- Current Assignee Address: CH Coinsins, Vaud
- Agency: Saliwanchik, Lloyd & Saliwanchik
- Priority: EP05110205 20051031
- International Application: PCT/EP2006/067939 WO 20061030
- International Announcement: WO2007/051781 WO 20070510
- Main IPC: C12N15/62
- IPC: C12N15/62 ; C12N15/63 ; A61K38/00 ; C07K14/00 ; C07H21/04
Abstract:
A novel CXC-chemokine binding protein is cloned from the salivary glands of Rhipicephalus sanguineus. Compounds prepared in accordance with the present invention can be used as anti-inflammatory and immuno-modulatory compounds and in the treatment or prevention of CXC-chemokine-related diseases.
Public/Granted literature
- US20080227711A1 Cxc-Chemokine Antagonists Public/Granted day:2008-09-18
Information query
IPC分类:
